rs2066734

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000051.4(ATM):​c.72+37_72+38del variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.414 in 1,612,058 control chromosomes in the GnomAD database, including 142,105 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 11205 hom., cov: 0)
Exomes 𝑓: 0.42 ( 130900 hom. )

Consequence

ATM
NM_000051.4 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.268
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 11-108227732-TAA-T is Benign according to our data. Variant chr11-108227732-TAA-T is described in ClinVar as [Benign]. Clinvar id is 1178525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-108227732-TAA-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.509 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ATMNM_000051.4 linkuse as main transcriptc.72+37_72+38del intron_variant ENST00000675843.1 NP_000042.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ATMENST00000675843.1 linkuse as main transcriptc.72+37_72+38del intron_variant NM_000051.4 ENSP00000501606 P1

Frequencies

GnomAD3 genomes
AF:
0.363
AC:
55042
AN:
151744
Hom.:
11200
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.172
Gnomad AMI
AF:
0.311
Gnomad AMR
AF:
0.505
Gnomad ASJ
AF:
0.496
Gnomad EAS
AF:
0.392
Gnomad SAS
AF:
0.526
Gnomad FIN
AF:
0.388
Gnomad MID
AF:
0.642
Gnomad NFE
AF:
0.420
Gnomad OTH
AF:
0.415
GnomAD3 exomes
AF:
0.435
AC:
109355
AN:
251264
Hom.:
25210
AF XY:
0.442
AC XY:
60011
AN XY:
135832
show subpopulations
Gnomad AFR exome
AF:
0.163
Gnomad AMR exome
AF:
0.566
Gnomad ASJ exome
AF:
0.486
Gnomad EAS exome
AF:
0.388
Gnomad SAS exome
AF:
0.517
Gnomad FIN exome
AF:
0.387
Gnomad NFE exome
AF:
0.423
Gnomad OTH exome
AF:
0.460
GnomAD4 exome
AF:
0.419
AC:
611621
AN:
1460196
Hom.:
130900
AF XY:
0.423
AC XY:
307658
AN XY:
726560
show subpopulations
Gnomad4 AFR exome
AF:
0.167
Gnomad4 AMR exome
AF:
0.558
Gnomad4 ASJ exome
AF:
0.478
Gnomad4 EAS exome
AF:
0.397
Gnomad4 SAS exome
AF:
0.519
Gnomad4 FIN exome
AF:
0.389
Gnomad4 NFE exome
AF:
0.413
Gnomad4 OTH exome
AF:
0.420
GnomAD4 genome
AF:
0.363
AC:
55057
AN:
151862
Hom.:
11205
Cov.:
0
AF XY:
0.370
AC XY:
27447
AN XY:
74208
show subpopulations
Gnomad4 AFR
AF:
0.172
Gnomad4 AMR
AF:
0.505
Gnomad4 ASJ
AF:
0.496
Gnomad4 EAS
AF:
0.393
Gnomad4 SAS
AF:
0.526
Gnomad4 FIN
AF:
0.388
Gnomad4 NFE
AF:
0.420
Gnomad4 OTH
AF:
0.418
Alfa
AF:
0.406
Hom.:
2401
Bravo
AF:
0.360
Asia WGS
AF:
0.479
AC:
1662
AN:
3472

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanNov 12, 2023This variant is classified as Benign based on local population frequency. This variant was detected in 70% of patients studied by a panel of primary immunodeficiencies. Number of patients: 67. Only high quality variants are reported. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingClinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute-- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Hereditary breast ovarian cancer syndrome Benign:1
Benign, criteria provided, single submitterclinical testingNational Health Laboratory Service, Universitas Academic Hospital and University of the Free StateApr 19, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.20
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.20
Position offset: -36

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2066734; hg19: chr11-108098459; COSMIC: COSV53723852; COSMIC: COSV53723852; API